JPS51127093A - Betaalactam containing compound - Google Patents

Betaalactam containing compound

Info

Publication number
JPS51127093A
JPS51127093A JP51042313A JP4231376A JPS51127093A JP S51127093 A JPS51127093 A JP S51127093A JP 51042313 A JP51042313 A JP 51042313A JP 4231376 A JP4231376 A JP 4231376A JP S51127093 A JPS51127093 A JP S51127093A
Authority
JP
Japan
Prior art keywords
betaalactam
containing compound
compound
betaalactam containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51042313A
Other languages
English (en)
Inventor
Torefuoo Hawaasu Toomasu
Guudoakua Jienifuaa
Jiyon Ponsufuoodo Rogaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS51127093A publication Critical patent/JPS51127093A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02Preparation
    • C07D503/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
JP51042313A 1975-04-14 1976-04-13 Betaalactam containing compound Pending JPS51127093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GB3967175 1975-09-27

Publications (1)

Publication Number Publication Date
JPS51127093A true JPS51127093A (en) 1976-11-05

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51042313A Pending JPS51127093A (en) 1975-04-14 1976-04-13 Betaalactam containing compound

Country Status (22)

Country Link
JP (1) JPS51127093A (ja)
AR (1) AR208773A1 (ja)
AT (1) AT342199B (ja)
AU (1) AU497577B2 (ja)
CA (1) CA1074802A (ja)
CH (1) CH602742A5 (ja)
DE (1) DE2616088A1 (ja)
DK (1) DK144066C (ja)
ES (1) ES446468A1 (ja)
FI (1) FI760946A (ja)
FR (1) FR2336130A1 (ja)
GR (1) GR58256B (ja)
HU (1) HU175444B (ja)
IE (1) IE42666B1 (ja)
IL (1) IL49279A (ja)
LU (1) LU74749A1 (ja)
MX (1) MX3453E (ja)
NL (1) NL7603840A (ja)
NO (1) NO761241L (ja)
PT (1) PT64897B (ja)
SE (1) SE427037B (ja)
YU (1) YU69476A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
ES446468A1 (es) 1977-11-01
GR58256B (en) 1977-09-15
HU175444B (hu) 1980-08-28
DK156576A (da) 1976-10-15
YU69476A (en) 1982-05-31
MX3453E (es) 1980-12-03
ATA215576A (de) 1977-07-15
NO761241L (ja) 1976-10-15
IE42666B1 (en) 1980-09-24
FI760946A (ja) 1976-10-15
SE7604287L (sv) 1976-10-15
CH602742A5 (ja) 1978-07-31
FR2336130A1 (fr) 1977-07-22
PT64897B (en) 1977-08-18
AR208773A1 (es) 1977-02-28
AU1302076A (en) 1977-10-20
IL49279A0 (en) 1976-06-30
DE2616088A1 (de) 1976-10-28
DK144066C (da) 1982-05-10
AU497577B2 (en) 1978-12-21
LU74749A1 (ja) 1976-11-11
DK144066B (da) 1981-11-30
IE42666L (en) 1976-10-14
PT64897A (en) 1976-04-01
SE427037B (sv) 1983-02-28
CA1074802A (en) 1980-04-01
AT342199B (de) 1978-03-28
NL7603840A (nl) 1976-10-18
IL49279A (en) 1979-05-31
FR2336130B1 (ja) 1979-06-22

Similar Documents

Publication Publication Date Title
GB1539006A (en) Aminoalkylammonium compound
JPS51123915A (en) Compound device
JPS57112389A (en) 1-sulfonylbenzimidazole compound
JPS51113900A (en) Riphamycin compound
JPS5268104A (en) Symmetric bisscarbamate compounds
JPS5273891A (en) Novel cephalospoline compound
JPS5236632A (en) Composition containing impurityydecreasing bissbiguanide
GB1557482A (en) Substituted tetranorprostaglandins
JPS51136694A (en) Novel antiibacterial compound
JPS5223076A (en) Antiiinflammatory compound
HK2482A (en) 3-acyloxymethyl-cephem compounds
ZA764267B (en) Sulphine compounds
JPS51143699A (en) Riphamycin compound
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
JPS51115450A (en) Phosphorrcontaining compounds
JPS5231062A (en) Perfluoroalkylthionorbornane compound
JPS5231095A (en) Cephlosporin type compound
JPS56142292A (en) Novel compound
JPS5278869A (en) Thienylpolyene compound
JPS5285106A (en) Carbamateesulphenyllcarbamoylfluoride compounds
ZM576A1 (en) Compounds
JPS5259624A (en) Compound capsulated
JPS5265276A (en) Substituted tetraalkylpiperidinee44oxime
AU1735076A (en) Substituted sulfoximides
JPS5271454A (en) Compound